• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AUTOGEN; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AUTOGEN; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G179
Device Problems Signal Artifact/Noise (1036); High impedance (1291)
Patient Problems No Known Impact Or Consequence To Patient (2692); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/13/2020
Event Type  malfunction  
Manufacturer Narrative
This product has not been returned to boston scientific, and as a result, laboratory analysis could not be conducted.Please refer to the description for more information regarding the specific circumstances of this event.
 
Event Description
It was reported that, during device interrogation, this cardiac resynchronization therapy defibrillator (crt-d) exhibited high out of range shock impedance measurements, measuring greater than 128 ohms.All other measurements were stable.Boston scientific technical services also noted that the shock impedance alert was triggered approximately 2 months prior where patient received an anti-tachycardia pacing (atp) therapy with shock impedances high out of range greater than 125 ohms.There was no oversensing.Technical services discussed possible causes and provided programming options.Health care professional (hcp) will discuss plan with cardiologist and continue to monitor this patient.No adverse patient effects were reported.This product remains in service.
 
Event Description
It was reported that, during device interrogation, this cardiac resynchronization therapy defibrillator (crt-d) exhibited high out of range shock impedance measurements, measuring greater than 128 ohms.All other measurements were stable.Boston scientific technical services also noted that the shock impedance alert was triggered approximately 2 months prior where patient received an anti-tachycardia pacing (atp) therapy with shock impedances high out of range greater than 125 ohms.There was no oversensing.Technical services discussed possible causes and provided programming options.Health care professional (hcp) will discuss plan with cardiologist and continue to monitor this patient.No adverse patient effects were reported.This product remains in service.Additional information was provided on 19oct2021, it was reported that this cardiac resynchronization therapy defibrillator (crt-d) triggered a high out of range pacing impedance measurement, measuring greater than 3000 ohms in the right atrial channel upon device interrogation.Review of past trend noted multiple out of range atrial lead impedances and episodes of noise was recorded.Shock lead impedance had occasional increases to over 125 ohms, but mostly impedances were less than 100 ohms.Boston scientific technical services provided information to healthcare professional and discussed probable causes.No adverse patient effects were reported.This crt-d, competitor right atrial and competitor right ventricular lead remains in service.
 
Manufacturer Narrative
Additional information was provided in section b5 and h10.This product has not been returned to boston scientific, and as a result, laboratory analysis could not be conducted.The associated investigation determined that this device exhibited intermittent impedance measurements with no conclusive evidence of a malfunction or inadequate lead-to-device connection.Engineering analysis and testing of returned products identified that any repeated, small movements of the lead terminal ring can create wearing of the lead terminal ring and generate microscopic particles, which may accumulate and oxidize over time.This can impact the connection between the spring contact and the lead ring, resulting in intermittent changes in impedance measurements.This product has not been returned to boston scientific, and as a result, laboratory analysis could not be conducted.Please refer to the description for more information regarding the specific circumstances of this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AUTOGEN
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key11104593
MDR Text Key224804838
Report Number2124215-2020-25290
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Reporter Country CodeCA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/06/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date12/03/2016
Device Model NumberG179
Device Catalogue NumberG179
Device Lot Number127957
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/05/2020
Initial Date FDA Received01/02/2021
Supplement Dates Manufacturer Received10/19/2021
Supplement Dates FDA Received01/06/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/03/2014
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Age86 YR
Patient SexFemale
-
-